BNET Industries
Market Cap:$7.3M
Last Fiscal Year Sales:$5.8M
- Public
- US
Dow Jones Description
Trimedyne, Inc. (the "Company", "we", "our" or "us") is engaged in the development, manufacturing and marketing of 80 and 30 watt Holmium "cold" pulsed lasers ("Lasers") and a variety of disposable and reusable, fiber optic laser energy delivery devices ("Fibers", "Needles" and "Tips") for use in a broad array of medical applications. Our Lasers, Fibers, Needles and Tips have been cleared for sale by the U.S. Food and Drug Administration ("FDA") for use in orthopedics, urology, ear, nose and throat ("ENT") surgery, gynecology, gastrointestinal surgery, general surgery and other medical specialties. Most of the medical procedures in which our Lasers, Fibers, Needles and Tips are used are being reimbursed by Medicare and most insurance companies and health plans. Our 100% owned subsidiary, Mobile Surgical Technologies, Inc. ("MST"), is engaged in the rental of lasers, along with the services of a trained operator and, if requested, the provision of applicable Fibers, Needles or Tips, on a "fee per case" basis to hospitals, surgery centers, group practices and individual physicians in Texas. MST's revenues and those of our field service department represented about 35% of our revenues in the fiscal year ended September 30, 2008.
Number of Employees 51
Contact Information
25901 Commercentre Dr
Lake Forest, California 92630-8805
(949) 951-3800
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
News & Analysis
Filter by
laser and trimedyne inc. - All News and Analysis
Trimedyne Announces U.S. Patent Office Allowance of Important Patent on New Laser Angioplasty Device
IRVINE, Calif. -- Trimedyne Inc. (OTCBB:TMED) today announced the U.S. Patent Office has allowed its Patent Application on a new laser angioplasty device. The Patent will issue in a few months. The Patent covers unique optical fiber devices designed to make smooth channels through plaque deposits in arteries, without...
Trimedyne Reports Sharply Lower Losses for the Quarter and Nine Months Ended June 30, 2002
Business Editors IRVINE, Calif.--BUSINESS WIRE--Aug. 23, 2002 Trimedyne Inc. (Nasdaq:TMED) today announced revenues of $1,896,000 and $5,408,000 for the quarter and nine month period ended June 30, 2002, respectively, compared with revenues of $1,829,000 and $5,445,000 for the quarter and nine month period ended June 30, 2001, respectively....
Gore Horvath Announces Investment Opinion on Trimedyne Inc
IRVINE, Calif.--BUSINESS WIRE--April 1, 1999-- Research Report on Trimedyne Issued by Gore Horvath Trimedyne Inc. (Nasdaq:TMED) Thursday announced the issuance of a Research Report and Speculative Buy Recommendation on Trimedyne by Gore Horvath, an investment banking firm with headquarters in Long Beach, Calif. The Gore Horvath report...
Patent Office Actions Benefit Trimedyne
IRVINE, Calif.--BUSINESS WIRE--March 8, 1999--Trimedyne Inc. (Nasdaq/NMS:TMED) Monday announced the U.S. Patent and Trademark Office ("USPTO") has completed the re-examination of Trimedyne's U.S. Patent on the use of a laser, drug injector or any other therapeutic device on the heart which is synchronized with the patient's electrocardiogram ("ECG"). The...
Trimedyne Reports Important Patent Office Actions
IRVINE, Calif.--BUSINESS WIRE--March 4, 1999--TRIMEDYNE INC. (Nasdaq/NMS: TMED) Thursday announced the U.S. Patent and Trademark Office ("USPTO") has completed the re-examination of Trimedyne's U.S. Patent on the use of a laser or any other therapeutic device on the heart which is synchronized with the patient's electrocardiogram ("ECG"). The Patent was...
Trimedyne Receives $6.5 Million Payment
IRVINE, Calif.--BUSINESS WIRE--Dec. 7, 1998--Trimedyne Inc. (Nasdaq/NMS:TMED) Monday announced it received the $6.5 million payment from C.R. Bard Inc. due under the settlement agreement reached in late November. As a result of this payment, Trimedyne's stockholders' equity has increased to approximately $16,870,000 or $1.55 per share as of this...
Trimedyne Inc. files action against C.R. Bard
IRVINE, Calif.--BUSINESS WIRE--Oct. 9, 1995--Trimedyne Inc. (NASDAQ:TMED) Monday announced that it has filed a lawsuit in the Superior Court of the state of California against C.R. Bard Inc. This action involves the 1991 Agreement between Trimedyne and Bard covering sales and marketing rights of the Urolaser device and other side-firing...
- 1
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes



